Cost-effectiveness of brief structured interventions to discontinue long-term benzodiazepine use: an economic analysis alongside a randomised controlled trial [version 1; peer review: 2 approved]

Background: In Spain, long-term use of benzodiazepine is prevalent in 7% of the population; however, this longer-term use lacks clinical benefits, costs €90million per year and side-effects further add extra cost through adverse health outcomes. This study aims to estimate the cost-effectiveness of...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Dominic Trépel, Shehzad Ali, Simon Gilbody, Alfonso Leiva, Dean Mcmillan, Ferran Bejarano, Ermengol Sempere, Caterina Vicens
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: F1000 Research Ltd 2020-06-01
Cyfres:HRB Open Research
Mynediad Ar-lein:https://hrbopenresearch.org/articles/3-33/v1